Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05505045 · ClinicalTrials.gov registry record · NA
Metacognitive Strategy Training in Cancer-related Cognitive Impairment
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT05505045 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 46 participants.
The verdict
NCT05505045, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The first aim of this study is to determine the feasibility of delivering CO-OP remotely to breast cancer survivors, who self-report cancer-related cognitive impairment (CRCI), in preparation for a future R01 trial. The second aim of this study is to assess the effect of CO-OP on activity performance, subjective and objective cognition, and quality of life in a sample of breast cancer survivors who self-report CRCI. The research team hypothesizes that effect size estimations will indicate that CO-OP will have a greater positive effect, compared to attention control, on activity performance, subjective and objective cognition, and quality of life in a sample of breast cancer survivors who self-report CRCI.
Interventions
- BEHAVIORAL CO-OP Procedures
- BEHAVIORAL Attention Control Procedures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2022-10-11 |
| Est. Completion | 2024-04-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05505045
The ClinicalTrials.gov registry entry for NCT05505045 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CO-OP Procedures is the first listed.
NCT05505045 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05505045 about?
NCT05505045 is a clinical study titled "Metacognitive Strategy Training in Cancer-related Cognitive Impairment". The first aim of this study is to determine the feasibility of delivering CO-OP remotely to breast cancer survivors, who self-report cancer-related cognitive impairment (CRCI), in preparation for a future R01 trial. The second aim of this study is to assess the effect of CO-OP on activity performanc...
What is the current status of trial NCT05505045?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2022-10-11. Estimated completion is 2024-04-04.
What interventions are being tested in trial NCT05505045?
The interventions under investigation include: CO-OP Procedures (BEHAVIORAL), Attention Control Procedures (BEHAVIORAL).
Who is sponsoring clinical trial NCT05505045?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.